S&P 500   2,990.48 (-0.17%)
DOW   27,022.09 (-0.01%)
QQQ   192.84 (-0.35%)
AAPL   233.87 (-0.62%)
FB   188.75 (-0.07%)
MSFT   139.98 (-1.12%)
GOOGL   1,245.38 (+0.25%)
CGC   19.72 (-1.89%)
NVDA   196.71 (+0.17%)
BABA   176.36 (+0.61%)
GE   9.02 (+1.35%)
TSLA   260.77 (+1.12%)
AMD   31.15 (+1.40%)
ACB   3.67 (-2.39%)
BAC   30.30 (+1.92%)
GILD   65.66 (+0.55%)
DIS   131.32 (+1.20%)
S&P 500   2,990.48 (-0.17%)
DOW   27,022.09 (-0.01%)
QQQ   192.84 (-0.35%)
AAPL   233.87 (-0.62%)
FB   188.75 (-0.07%)
MSFT   139.98 (-1.12%)
GOOGL   1,245.38 (+0.25%)
CGC   19.72 (-1.89%)
NVDA   196.71 (+0.17%)
BABA   176.36 (+0.61%)
GE   9.02 (+1.35%)
TSLA   260.77 (+1.12%)
AMD   31.15 (+1.40%)
ACB   3.67 (-2.39%)
BAC   30.30 (+1.92%)
GILD   65.66 (+0.55%)
DIS   131.32 (+1.20%)
Log in

FRESENIUS SE &/S News Headlines (OTCMKTS:FSNUY)

$12.23
+0.31 (+2.60 %)
(As of 10/16/2019 12:42 PM ET)
Today's Range
$12.17
Now: $12.23
$12.23
50-Day Range
$11.10
MA: $11.98
$12.63
52-Week Range
$11.00
Now: $12.23
$20.04
Volume9,723 shs
Average Volume59,805 shs
Market Capitalization$27.24 billion
P/E Ratio15.48
Dividend Yield1.29%
Beta1.22

Headlines

FRESENIUS SE &/S (OTCMKTS FSNUY) News Headlines

Source:
DateHeadline
Is Fresenius SE & Co. KGaA (ETR:FRE) An Attractive Dividend Stock?Is Fresenius SE & Co. KGaA (ETR:FRE) An Attractive Dividend Stock?
finance.yahoo.com - October 4 at 5:51 AM
FRESENIUS SE &/S (OTCMKTS:FSNUY) Receives Average Rating of "Hold" from AnalystsFRESENIUS SE &/S (OTCMKTS:FSNUY) Receives Average Rating of "Hold" from Analysts
www.americanbankingnews.com - October 3 at 2:41 AM
Brokers Offer Predictions for FRESENIUS SE &/Ss FY2019 Earnings (OTCMKTS:FSNUY)Brokers Offer Predictions for FRESENIUS SE &/S's FY2019 Earnings (OTCMKTS:FSNUY)
www.americanbankingnews.com - September 23 at 1:59 AM
Is Fresenius SE KGaA (FRA:FRE) Using Too Much Debt?Is Fresenius SE KGaA (FRA:FRE) Using Too Much Debt?
finance.yahoo.com - August 20 at 8:20 AM
Sanofi prevails in Jevtana patent disputeSanofi prevails in Jevtana patent dispute
seekingalpha.com - August 14 at 5:46 PM
Generic Injectables Market to Worth US$ 49.8 Billion by 2024 | CAGR of 9.4 % – IMARC GroupGeneric Injectables Market to Worth US$ 49.8 Billion by 2024 | CAGR of 9.4 % – IMARC Group
www.marketwatch.com - August 8 at 6:04 PM
Why Fresenius Is the Initial Winner From Trump's Kidney Disease OverhaulWhy Fresenius Is the Initial Winner From Trump's Kidney Disease Overhaul
finance.yahoo.com - July 12 at 5:13 PM
Selling Your Business Later: 5 Must-Dos NowSelling Your Business Later: 5 Must-Do's Now
www.forbes.com - June 11 at 5:31 PM
Fresenius talking to potential suitors about sale of blood transfusion business - sourcesFresenius talking to potential suitors about sale of blood transfusion business - sources
finance.yahoo.com - May 10 at 5:36 PM
CTSO: Distributor Sales Take a Breather But Expected to Rebound. Direct Sales Remain RobustCTSO: Distributor Sales Take a Breather But Expected to Rebound. Direct Sales Remain Robust
finance.yahoo.com - May 9 at 5:57 PM
What Kind Of Shareholder Owns Most Fresenius SE  Co. KGaA (FRA:FRE) Stock?What Kind Of Shareholder Owns Most Fresenius SE Co. KGaA (FRA:FRE) Stock?
finance.yahoo.com - April 8 at 11:37 AM
Glancy Prongay & Murray LLP Announces Investigation on Behalf of Akorn, Inc. InvestorsGlancy Prongay & Murray LLP Announces Investigation on Behalf of Akorn, Inc. Investors
globenewswire.com - March 8 at 5:57 PM
United Kingdom Ambulatory Services Market Outlook to 2025 - Projected to Reach $176 Billion, Growing at a CAGR of 8.5% - ResearchAndMarkets.comUnited Kingdom Ambulatory Services Market Outlook to 2025 - Projected to Reach $176 Billion, Growing at a CAGR of 8.5% - ResearchAndMarkets.com
www.finanznachrichten.de - March 6 at 10:10 AM
Home Healthcare Market is Anticipated to Touch US$ 424 billion by 2024Home Healthcare Market is Anticipated to Touch US$ 424 billion by 2024
www.marketwatch.com - February 27 at 5:37 PM
Union calls on Fresenius hospital staff to strikeUnion calls on Fresenius hospital staff to strike
www.reuters.com - February 20 at 5:30 PM
Intravenous (IV) Therapy and Vein Access Market Competitive Strategies, Regional Analysis Forecast 2024Intravenous (IV) Therapy and Vein Access Market Competitive Strategies, Regional Analysis Forecast 2024
www.marketwatch.com - February 14 at 10:03 AM
Home Healthcare Market By Product Segment Analysis is Determined to Cross US$ 424.0 billion by 2024Home Healthcare Market By Product Segment Analysis is Determined to Cross US$ 424.0 billion by 2024
www.marketwatch.com - February 12 at 10:03 AM
Heparin Market 2025 opportunities illuminated by new report | Credence ResearchHeparin Market 2025 opportunities illuminated by new report | Credence Research
www.marketwatch.com - February 5 at 5:11 PM
DGAP-News: Nanogate SE: Change to the Supervisory BoardDGAP-News: Nanogate SE: Change to the Supervisory Board
www.marketwatch.com - February 4 at 10:01 AM
The $4.3 Billion Deal That Blew Up Over Shoddy Drug ProductionThe $4.3 Billion Deal That Blew Up Over Shoddy Drug Production
www.bloomberg.com - February 1 at 10:05 AM
Home Healthcare Market to Rise US$ 424.0 billion by 2024Home Healthcare Market to Rise US$ 424.0 billion by 2024
www.marketwatch.com - January 31 at 5:14 PM
Anesthesia Drugs Market Demand, Challenges and Opportunities by Trends, Size, Share, Segmentation, Geographical Overview by MRFR till 2023Anesthesia Drugs Market Demand, Challenges and Opportunities by Trends, Size, Share, Segmentation, Geographical Overview by MRFR till 2023
www.marketwatch.com - January 29 at 9:51 AM
Ottobock makes Schulte-Noelle permanent CEO as it eyes IPOOttobock makes Schulte-Noelle permanent CEO as it eyes IPO
www.reuters.com - January 22 at 9:50 AM
Home Healthcare Market Set for Rapid Growth During by 2020Home Healthcare Market Set for Rapid Growth During by 2020
www.marketwatch.com - January 21 at 4:46 PM
Blood Collection Market to Expand at a steady Growth Rate in the Coming YearsBlood Collection Market to Expand at a steady Growth Rate in the Coming Years
www.marketwatch.com - January 18 at 9:30 PM
FRESENIUS - BNP Paribas Primary New Issues: NO STAB NoticeFRESENIUS - BNP Paribas Primary New Issues: NO STAB Notice
globenewswire.com - January 16 at 4:49 PM
Fresenius SE & Co. KGaA (FRA:FRE): A Fundamentally Attractive InvestmentFresenius SE & Co. KGaA (FRA:FRE): A Fundamentally Attractive Investment
finance.yahoo.com - January 14 at 4:57 PM
UPDATE 2-Akorn gets FDA warning letter for Illinois plantUPDATE 2-Akorn gets FDA warning letter for Illinois plant
www.cnbc.com - January 10 at 10:18 AM
UPDATE 1-Akorn gets FDA warning letter for Illinois plantUPDATE 1-Akorn gets FDA warning letter for Illinois plant
www.cnbc.com - January 9 at 5:28 PM
Akorn gets FDA warning letter for Illinois plant, shares dropAkorn gets FDA warning letter for Illinois plant, shares drop
www.reuters.com - January 9 at 5:28 PM
NantCell Announces New Celgene InvestmentNantCell Announces New Celgene Investment
www.bizjournals.com - January 5 at 9:41 AM
After court case loss, drug maker Akorns CEO will step downAfter court case loss, drug maker Akorn's CEO will step down
www.bizjournals.com - December 10 at 4:29 PM
Fresenius Wins Ruling on Canceled Buyout; Akorn Shares FallFresenius Wins Ruling on Canceled Buyout; Akorn Shares Fall
finance.yahoo.com - December 7 at 4:29 PM
European markets rally after global sell-off; Fresenius SE shares tank 10%European markets rally after global sell-off; Fresenius SE shares tank 10%
www.cnbc.com - December 7 at 9:30 AM
Akorn-Fresenius Fight Over Canceled Deal Heads to Appeals CourtAkorn-Fresenius Fight Over Canceled Deal Heads to Appeals Court
www.bloomberg.com - December 5 at 4:22 PM
UBS to Danske Bank Enter Hidden Debt Market as Europe Loans CoolUBS to Danske Bank Enter Hidden Debt Market as Europe Loans Cool
www.bloomberg.com - December 5 at 9:34 AM
Is FRESENIUS SE&CO (FSNUY) Stock Undervalued Right Now?Is FRESENIUS SE&CO (FSNUY) Stock Undervalued Right Now?
finance.yahoo.com - November 22 at 4:21 PM
Interested In Fresenius SE & Co KGaA (FRA:FRE)? Here’s What Its Recent Performance Looks LikeInterested In Fresenius SE & Co KGaA (FRA:FRE)? Here’s What Its Recent Performance Looks Like
finance.yahoo.com - November 21 at 4:16 PM
Home Healthcare Market By Product Analysis is Expected to Grow more than US$ 349 Billion By 2022Home Healthcare Market By Product Analysis is Expected to Grow more than US$ 349 Billion By 2022
www.marketwatch.com - November 20 at 4:22 PM
Home Healthcare Market Growth Factors Analysis, Product Overview and Share Forecasted to 2020Home Healthcare Market Growth Factors Analysis, Product Overview and Share Forecasted to 2020
www.marketwatch.com - November 16 at 4:31 PM
Investor Alert - Akorn, Inc. (AKRX) – Kehoe Law Firm, P.C. Investigating Potential Claims Against Certain Officers and Directors of Akorn, Inc.Investor Alert - Akorn, Inc. (AKRX) – Kehoe Law Firm, P.C. Investigating Potential Claims Against Certain Officers and Directors of Akorn, Inc.
globenewswire.com - November 12 at 9:22 AM
Mid-Day Update: Election Results Fuel Outsized Gains on Wall StreetMid-Day Update: Election Results Fuel Outsized Gains on Wall Street
www.nasdaq.com - November 7 at 4:26 PM
Here's Why Akorn, Inc. Fell 48.6% in OctoberHere's Why Akorn, Inc. Fell 48.6% in October
finance.yahoo.com - November 5 at 4:16 PM
Home Healthcare Market to Perceive Substantial Growth During 2020Home Healthcare Market to Perceive Substantial Growth During 2020
www.marketwatch.com - October 23 at 9:38 AM
Akorns Generic Drug For Inadequate Eye Lashes Receives FDA NodAkorn's Generic Drug For Inadequate Eye Lashes Receives FDA Nod
www.benzinga.com - October 10 at 4:07 PM
Akorn Plunges After Judge Backs Fresenius Exit From DealAkorn Plunges After Judge Backs Fresenius Exit From Deal
www.bloomberg.com - October 2 at 9:26 AM
Judge says Fresenius can walk away from $4.8 billion Akorn dealJudge says Fresenius can walk away from $4.8 billion Akorn deal
www.reuters.com - October 1 at 4:11 PM
Judge Finds Akorns Miscues Justified Fresenius Exit From DealJudge Finds Akorn's Miscues Justified Fresenius Exit From Deal
finance.yahoo.com - October 1 at 4:11 PM
Global Infusion Pump Market to Witness a CAGR of 6.6% during 2018-2024Global Infusion Pump Market to Witness a CAGR of 6.6% during 2018-2024
www.benzinga.com - September 20 at 9:53 AM
Global Bi-Specific Antibodies Market Forecast to 2022 - Increasing Demand for Bi-Specific/Double Barreled AntibodiesGlobal Bi-Specific Antibodies Market Forecast to 2022 - Increasing Demand for Bi-Specific/Double Barreled Antibodies
www.marketwatch.com - September 5 at 9:50 AM
This page was last updated on 10/16/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel